Table 1 The ATC classification of the products evaluated
ATC index | Number of medicines included in the study | Number of different product labels (brands/branded generics/generics) evaluated | |
|---|---|---|---|
N03 | Antiepileptics | 6 | 10 |
N05 | Psycholeptics | 3 | 7 |
N06 | Psychoanaleptic | 1 | 3 |
C05 | Vasoprotectives | 1 | 1 |
C07 | Beta blocking agents | 1 | 3 |
C08 | Calcium channel blockers | 2 | 6 |
C09 | Agents acting on the renin–angiotensin system | 4 | 26 |
C10 | Serum lipid reducing agents | 2 | 29 |
J01 | Antibacterial for systemic use | 10 | 29 |
J05 | Antivirals | 1 | 1 |
B01 | Antithrombotic agents | 2 | 15 |
M01 | Anti-inflammatory and antirheumatic products | 3 | 13 |
M05 | Drugs for treatment of bone diseases | 1 | 1 |
A02 | Drugs for acid related disorders | 4 | 14 |
A03 | Drugs for functional gastrointestinal disorders | 1 | 5 |
A10 | Drugs used in diabetes | 6 | 39 |
H02 | Corticosteroids for systemic use | 1 | 3 |
H03 | Thyroid therapy | 1 | 1 |
R03 | Drugs for obstructive airway disease | 1 | 6 |
G04 | Urologicals | 1 | 3 |
P02 | Anthelmintics | 1 | 1 |
Total | 53 | 216 | |